BOSTON, April 12, 2018 --
|
|||||
As educators across the country strive to align their instructional plans with the requirements of the Every Student Succeeds Act (ESSA), Lexia Learning, a Rosetta Stone Inc. (NYSE: RST) Company, stands apart with an unmatched depth and strength of evidence of program effectiveness.
ESSA requires Title I schools to utilize evidence-based instructional programs that have demonstrated positive effects on student learning outcomes. This focus on efficacy has established a more rigorous standard for proving what’s working in classrooms and helps schools, districts, and states to shape the future of teaching and learning. Lexia, with a 30-year history of efficacy research, has multiple studies demonstrating the strongest level of evidence according to ESSA legislation.
ESSA legislation categorizes evidence into three different levels: Strong, Moderate and Promising. Lexia has eight studies with Strong evidence—the highest level of rigor defined by ESSA—and an additional seven studies with Moderate or Promising evidence.
- Strong evidence is defined as well-designed, well-implemented experimental studies that include randomly assigned treatment and control groups to eliminate selection biases. This is the highest level of evidence as defined by ESSA, and Lexia has eight studies in this category.
- Moderate evidence is defined as well-designed, well-implemented quasi-experimental studies with treatment and control groups that may not be randomly assigned. There may be some selection biases that are statistically addressed. Lexia has three studies with Moderate evidence.
- Promising studies include correlational evidence that the program has an impact. These studies may not include a control group, but selection effects are addressed statistically. This is the lowest level of evidence as defined by ESSA, and Lexia has four studies in this category.
“The requirements of ESSA underscore the approach Lexia has taken for more than three decades,” said Lexia President Nick Gaehde. “Educators should have confidence that the instructional resources they choose will deliver a statistically significant impact on student outcomes; and Lexia’s 15 efficacy studies not only satisfy the requirements under ESSA, but provide scientific evidence of our programs’ effectiveness.”
More information about Lexia’s efficacy research can be found at www.lexialearning.com/research.
Lexia’s flagship product is Lexia Reading Core5, a research-proven, technology-based program that accelerates the development of fundamental literacy skills for students of all abilities in grades pre-K–5. Following a scope and sequence built for rigorous state standards, Core5 provides explicit, systematic instruction through personalized learning paths in six areas of reading. Core5 seamlessly adapts based on student performance, targeting skill gaps as they emerge and equipping teachers with the data and instructional resources they need to personalize instruction for every student. Embedded assessment technology predicts students’ year-end performance and provides ongoing norm-referenced and actionable data to help teachers prioritize and plan instruction with the offline instructional materials.
# # #
About Lexia Learning
Lexia Learning, a Rosetta Stone company, empowers educators through adaptive assessment and personalized instruction. For more than 30 years, the company has been on the leading edge of research and product development as it relates to student reading skills. With a robust offering that includes solutions for differentiated instruction, personalized learning and assessment, Lexia Learning provides educators with the tools to intensify and accelerate literacy skills development for students of all abilities. For more information, visit www.lexialearning.com.
About Rosetta Stone
Rosetta Stone Inc. (NYSE: RST) is dedicated to changing people’s lives through the power of language and literacy education. The company’s innovative digital solutions drive positive learning outcomes for the inspired learner at home or in schools and workplaces around the world.
Founded in 1992, Rosetta Stone’s language division uses cloud-based solutions to help all types of learners read, write, and speak more than 30 languages. Lexia Learning, Rosetta Stone's literacy education division, was founded more than 30 years ago and is a leader in the literacy education space. Today, Lexia helps students build fundamental reading skills through its rigorously researched, independently evaluated, and widely respected instruction and assessment programs.
For more information, visit www.rosettastone.com. “Rosetta Stone” is a registered trademark or trademark of Rosetta Stone Ltd. in the United States and other countries.
Media Contact: Charlotte Andrist [email protected] 770-310-5244


Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings
GE Aerospace Expands Singapore Engine Repair Hub with Automation and AI to Tackle Aviation Bottlenecks
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
FTC Questions Apple News Over Alleged Bias Against Conservative Media
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
How Marco Pharma International Preserves German Homeopathic Traditions in America
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks 



